In: Journal of Antimicrobial Chemotherapy, 2018, vol. 73, no. 9, p. 2540-2545
|
In: European Journal of Clinical Microbiology & Infectious Diseases, 2015, vol. 34, no. 10, p. 2049-2055
|
In: Journal of Antimicrobial Chemotherapy, 2017, vol. 72, no. 5, p. 1462-1465
|
In: World Journal of Surgery, 2015, vol. 39, no. 9, p. 2274-2281
|
In: The Journal of Infectious Diseases, 2016, vol. 213, no. 9, p. 1370-1379
|
In: The Journal of Infectious Diseases, 2016, vol. 214, no. 10, p. 1610-1611
|
In: European Journal of Clinical Microbiology & Infectious Diseases, 2015, vol. 34, no. 10, p. 1937-1945
|
In: Current Infectious Disease Reports, 2015, vol. 17, no. 6, p. 1-5
|
In: World Journal of Surgery, 2015, vol. 39, no. 3, p. 769-775
|
In: Journal of Antimicrobial Chemotherapy, 2020, p. dkaa487
Objectives: To evaluate the in vivo efficacy of a dual carbapenem combination containing imipenem plus meropenem against carbapenem-resistant Acinetobacter baumannii producing carbapenemases OXA-23 or OXA-58.Methods: An experimental model of peritonitis using C57BL/6J female mice was developed and the minimum lethal doses were calculated for infections due to OXA-23 or OXA-58 producers of A. ...
|